首页 › 基金 › Boston Trust Walden Corp › HALO
Boston Trust Walden Corp 对 HALO 的持仓历史
HALOZYME THERAPEUTICS INC · 医疗保健
Boston Trust Walden Corp 在 Q3 2026 的 13F 申报中披露持有 HALO(HALOZYME THERAPEUTICS INC)1,035,813 股,市值约 US$114.4M,约占其申报组合的 0.92%,在其申报持仓中市值排名第 17 位。 Boston Trust Walden Corp 最近 10 个申报季度中有 10 个季度披露了 HALO 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Boston Trust Walden Corp 对 HALO 的持仓演变
Boston Trust Walden Corp 于 Q2 2024 首次披露 HALO 持仓:443,295 股(约 US$23.2M)。 该持仓在 Q3 2026 达到峰值 1,035,813 股,市值约 US$114.4M。 在 10 次申报中,Boston Trust Walden Corp 3 次增持、6 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,035,813 股、市值约 US$114.4M,环比减持 -47,249 股。。 持仓曾出现大幅变动:Q3 2024 增持约 54% (随后一个季度股价下跌 16%)、Q4 2024 增持约 28% (随后一个季度股价上涨 33%)、Q2 2026 增持约 59% (随后一个季度股价上涨 41%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 443.30K | $23.21M | 新进 |
| Q3 2024 | 682.62K | $39.07M | 增持 |
| Q4 2024 | 874.08K | $41.79M | 增持 |
| Q1 2025 | 866.87K | $55.32M | 减持 |
| Q2 2025 | 845.25K | $43.97M | 减持 |
| Q3 2025 | 833.89K | $61.16M | 减持 |
| Q4 2025 | 781.84K | $52.62M | 减持 |
| Q1 2026 | 679.56K | $43.92M | 减持 |
| Q2 2026 | 1.08M | $84.77M | 增持 |
| Q3 2026 | 1.04M | $114.35M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HALO 与 13F 数据
HALO(HALOZYME THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 HALO,申报仓位最大的包括:CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HALO 的基金
- CONGRESS ASSET MANAGEMENT CO 2.28M 股 · $251.89M · Q3 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M 股 · $187.54M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.62M 股 · $178.46M · Q3 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.58M 股 · $174.27M · Q3 2026
- Stephens Investment Management Group LLC 1.41M 股 · $156.00M · Q3 2026
- GW&K Investment Management, LLC 1.14M 股 · $125.86M · Q3 2026
- WASATCH ADVISORS LP 1.05M 股 · $115.88M · Q3 2026
- LMR Partners LLP 45.00M 股 · $65.81M · Q2 2026
更多关于 Boston Trust Walden Corp
常见问题
How long has Boston Trust Walden Corp held HALO?
Boston Trust Walden Corp has disclosed HALO holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Boston Trust Walden Corp's current position in HALO?
As of Q3 2026, Boston Trust Walden Corp holds 1.04M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $114.35M, representing 0.92% of its reported portfolio and ranking #17.
Has Boston Trust Walden Corp been buying or selling HALO?
In the latest 13F filing (Q3 2026), Boston Trust Walden Corp reduced its position in HALO. The position peaked in Q3 2026 at 1.04M shares.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.